[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 167,287
  • Shares Outstanding, K 41,874
  • Annual Sales, $ 52,840 K
  • Annual Income, $ -11,210 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.35
  • Price/Sales 3.29
  • Price/Cash Flow N/A
  • Price/Book 12.46

Options Overview Details

View History
  • Implied Volatility 112.00% (-14.26%)
  • Historical Volatility 99.94%
  • IV Percentile 11%
  • IV Rank 3.96%
  • IV High 691.79% on 09/03/25
  • IV Low 88.10% on 08/13/25
  • Expected Move (DTE 19) 0.90 (22.58%)
  • Put/Call Vol Ratio 13.00
  • Today's Volume 14
  • Volume Avg (30-Day) 610
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 5,042
  • Open Int (30-Day) 5,151
  • Expected Range 3.09 to 4.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.09
  • Growth Rate Est. (year over year) +1,110,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.76 +44.75%
on 05/05/26
4.41 -9.41%
on 05/15/26
+0.53 (+15.46%)
since 04/29/26
3-Month
2.76 +44.75%
on 05/05/26
4.41 -9.41%
on 05/15/26
+0.72 (+22.17%)
since 02/27/26
52-Week
1.41 +183.05%
on 06/02/25
4.50 -11.22%
on 02/02/26
+2.32 (+139.22%)
since 05/28/25

Most Recent Stories

More News
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

CLEARWATER, Fla. , May 27, 2026 /PRNewswire/ -- Apyx Medica l  Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leader in surgical aesthetics marketed and sold as Renuvion...

APYX : 3.99 (-3.73%)
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®

CLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as...

APYX : 3.99 (-3.73%)
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction

CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion...

APYX : 3.99 (-3.73%)
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as...

APYX : 3.99 (-3.73%)
Apyx: Q1 Earnings Snapshot

Apyx: Q1 Earnings Snapshot

APYX : 3.99 (-3.73%)
Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Reported total revenue of $12.5 million in the first quarter of 2026 primarily driven by 36% growth in the Surgical Aesthetics segment Raised total revenue guidance for FY2026 to a range of $59.0 million...

APYX : 3.99 (-3.73%)
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

CLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion...

APYX : 3.99 (-3.73%)
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

Renuvion continues to lead in minimally invasive body contouring as the trusted solution for loose skin.

APYX : 3.99 (-3.73%)
Apyx: Q4 Earnings Snapshot

Apyx: Q4 Earnings Snapshot

APYX : 3.99 (-3.73%)
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Reported record total revenue of $19.2 million in the fourth quarter of 2025 Scaling U.S. commercial launch of AYON Body Contouring System ™ (AYON) to meet strong market demand Expect FY2026...

APYX : 3.99 (-3.73%)

Business Summary

Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly...

See More

Key Turning Points

3rd Resistance Point 4.49
2nd Resistance Point 4.39
1st Resistance Point 4.19
Last Price 3.99
1st Support Level 3.89
2nd Support Level 3.78
3rd Support Level 3.59

See More

52-Week High 4.50
Last Price 3.99
Fibonacci 61.8% 3.32
Fibonacci 50% 2.96
Fibonacci 38.2% 2.59
52-Week Low 1.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.